AstraZeneca Pharma
-
AstraZeneca Pharma gets DCGI nod for lung cancer treatment drug
The oral pill has shown to decrease the risk of cancer recurrence by nearly 83 per cent AstraZeneca Pharma (AstraZeneca…
Read More » -
AstraZeneca Pharma gets DCGI nod to market asthma drug
AstraZeneca Pharma said the receipt of this permission paves way for the launch of Benralizumab (Fasenra) in India AstraZeneca Pharma…
Read More »